News:

This week IPhone 15 Pro winner is karn
You can be too a winner! Become the top poster of the week and win valuable prizes.  More details are You are not allowed to view links. Register or Login 

Main Menu

Pfizer arthritis drug rejected by European regulators

Started by riky, April 26, 2013, 09:00:21 AM

Previous topic - Next topic

0 Members and 1 Guest are viewing this topic.

riky

Pfizer arthritis drug rejected by European regulators

<p><a href="http://news.yahoo.com/pfizers-arthritis-drug-rejected-european-regulators-203927579--finance.html"><img src="http://l3.yimg.com/bt/api/res/1.2/DqSkjdaX05CiIJBf5JWW_A--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-04-25T203927Z_1_CBRE93O1LDW00_RTROPTP_2_PFIZER.JPG" width="130" height="86" alt="A woman walks past the Pfizer Inc. headquarters in New York" align="left" title="A woman walks past the Pfizer Inc. headquarters in New York" border="0" /></a>(Reuters) - European regulators declined to approve marketing of Pfizer Inc's new rheumatoid arthritis treatment Xeljanz, citing the risks of the drug compared with its potential benefit, the company said on Thursday. Pfizer said it plans to appeal and &quot;immediately seek a re-examination of the opinion&quot; by the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP). Shares of Pfizer, which rose 1 percent to close at $30.26 on the New York Stock Exchange, were down 2.7 percent at $29.45 after hours. ...</p><br clear="all"/>

Source: You are not allowed to view links. Register or Login
You are not allowed to view links. Register or Login